Last edition
News about "Laurus Labs, Unitaid and CHAI ink agreement to acc"
Laurus Labs, Unitaid and CHAI ink agreement to accelerate development of HIV medication for children
Laurus Labs Limited, a leading research & development-driven and fully integrated pharmaceutical and biotech company in India, Unitaid and the Clinton Health Access Initiative (CHAI), announce agreement to accelerate the development, commercialization and registration of the bestin-class second- and third-line HIV treatment darunavir boosted
Laurus Labs, Unitaid And CHAI Ink Agreement To Acc | 15/09/2021 | By Darshana | 357
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy